Congratulations to Nallathamby lab’s @JohannaOlesk on successfully defending her Masters thesis for Bioengineering in Summer 2023. Her thesis was titled ” Phage-Mimicking Nanoparticles Conjugated with Antimicrobial Peptides and Polymers as an Alternative to Antibiotic Treatment.” She passed with unanimous consent. We wish her all the best in her future undertakings. #WomenInSTEM#notredame#GoIrish Special mention to all …
Category Archive: Thesis defense
Jul 07
Congratulations to Ms. Johanna Olesk on Defending her MS (Bioengineering) ’23 Thesis
Categories:
antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, Graduate Student, multidrug resistance, Thesis defense, Uncategorized
by Prakash
This post has no tag
Recent Posts
- Phage-Mimicking Antibacterial Nanoparticles Tackle Group A Streptococcal Infections In Vivo January 29, 2024
- 2nd Annual Berthiaume Institute for Precision Health’s Advisory Board Meeting October 30, 2023
- 1st Place Poster at the Military Health Sciences Research Symposium 2023 (Aug 14-17, Kissimmee, FL) August 14, 2023
- Congratulations to Ms. Johanna Olesk on Defending her MS (Bioengineering) ’23 Thesis July 7, 2023
- Translational Science to Impact Public Health was our Goal at Techconnect 2023 June 17, 2023
Archives
Categories
NIH Funding Opportunities
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) July 17, 2024Funding Opportunity RFA-OD-24-011 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to provide salary support for exceptional Research Software Engineers (RSEs) that contribute their skills to the development and dissemination of biomedical, behavioral or health related software, tools, and algorithms as well as to the […]
- Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) July 17, 2024Funding Opportunity RFA-OD-24-010 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to enhance the sustainability and impact of research software tools by enabling the use of best practices and design principles in software development and by leveraging continuing advances in computing. It is also expected […]
- Notice of Need to Expire and Reissue PAR-24-123 "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)" July 17, 2024Notice NOT-AT-24-046 from the NIH Guide for Grants and Contracts
- Notice of Information: Reissuance of Notices of Funding Opportunity (NOFO) Dissemination and Implementation Research in Health (R01, R21, R03) July 17, 2024Notice NOT-CA-24-052 from the NIH Guide for Grants and Contracts
- Notice of Pre-Application Webinar for NHLBI Phased Multi-site Clinical trial: Testing Prevention of Cardiovascular Disease in Young Adults with High Lifetime Risk using Surrogate Outcomes July 17, 2024Notice NOT-HL-24-021 from the NIH Guide for Grants and Contracts
- Single Audit Requirements for Foreign Recipients and Subrecipients of NIH Grants July 17, 2024Notice NOT-OD-24-151 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of Notice of Special Interest (NOSI): Halting Tuberculosis (TB) Transmission, NOT-AI-22-064 July 17, 2024Notice NOT-AI-24-055 from the NIH Guide for Grants and Contracts
- Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional) July 17, 2024Funding Opportunity RFA-AI-24-049 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to understand the critical drivers of tuberculosis (TB) transmission at the individual and population levels in high-burden settings; to develop effective methods to measure rates of TB transmission that rely on an increased understanding […]
- Bridges to the Doctorate Research Training Program (T32) July 17, 2024Funding Opportunity PAR-24-232 from the NIH Guide for Grants and Contracts. The goal of the Bridges to the Doctorate Research Training Program is topromote broad participation in the biomedical research workforce by strengthening research training environments and expanding the pool of well-trained masters students who transition to and complete biomedical Ph.Ds. Specifically, this funding announcement […]
- Clarification of Data Management and Sharing Plan Instructions in PAR-23-257 IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional) July 17, 2024Notice NOT-GM-24-037 from the NIH Guide for Grants and Contracts
Recent Comments